Cargando…

Genetic factors influencing the risk of multiple myeloma bone disease

A major complication of multiple myeloma (MM) is the development of osteolytic lesions, fractures and bone pain. To identify genetic variants influencing the development of MM bone disease (MBD), we analyzed MM patients of European ancestry (totaling 3774), which had been radiologically surveyed for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, D C, Weinhold, N, Mitchell, J, Chen, B, Stephens, O W, Försti, A, Nickel, J, Kaiser, M, Gregory, W A, Cairns, D, Jackson, G H, Hoffmann, P, Noethen, M M, Hillengass, J, Bertsch, U, Barlogie, B, Davis, F E, Hemminki, K, Goldschmidt, H, Houlston, R S, Morgan, G J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832071/ https://www.ncbi.nlm.nih.gov/pubmed/26669972 http://dx.doi.org/10.1038/leu.2015.342

Ejemplares similares

Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma
por: Johnson, David C., et al.
Publicado: (2016)

Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach
por: Went, M, et al.
Publicado: (2017)

Genome-wide interaction and pathway-based identification of key regulators in multiple myeloma
por: Chattopadhyay, Subhayan, et al.
Publicado: (2019)

Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients
por: Weinhold, Niels, et al.
Publicado: (2021)

Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression
por: Li, Ni, et al.
Publicado: (2016)

Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells
por: Meißner, Tobias, et al.
Publicado: (2015)

Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes
por: Went, Molly, et al.
Publicado: (2019)

Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism
por: Li, Ni, et al.
Publicado: (2017)

The CCND1 870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
por: Weinhold, Niels, et al.
Publicado: (2013)

Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
por: Broderick, Peter, et al.
Publicado: (2011)

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
por: Went, Molly, et al.
Publicado: (2018)

Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci
por: Law, Philip J., et al.
Publicado: (2017)

Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma
por: Niazi, Yasmeen, et al.
Publicado: (2022)

Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
por: Mitchell, Jonathan S., et al.
Publicado: (2016)

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
por: Rasche, L., et al.
Publicado: (2017)

Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma
por: Mitchell, Jonathan S., et al.
Publicado: (2015)

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients
por: Shah, V, et al.
Publicado: (2018)

Familial associations of lymphoma and myeloma with autoimmune diseases
por: Hemminki, K, et al.
Publicado: (2017)

Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial
por: Huhn, S, et al.
Publicado: (2017)

P879: EXENT AND FLC MASS SPECTROMETRY FOR SEROLOGICAL IDENTIFICATION AND QUANTIFICATION OF MONOCLONAL IMMUNOGLOBULINS IN MULTIPLE MYELOMA
por: Huhn, S., et al.
Publicado: (2022)

Impact of mitochondrial DNA mutations in multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2020)

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial
por: Jones, J R, et al.
Publicado: (2016)

Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis
por: Khandanpour, Cyrus, et al.
Publicado: (2021)

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
por: Went, Molly, et al.
Publicado: (2018)

A systematic classification of death causes in multiple myeloma
por: Mai, Elias K., et al.
Publicado: (2018)

Characterization of rare germline variants in familial multiple myeloma
por: Catalano, Calogerina, et al.
Publicado: (2021)

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
por: Went, Molly, et al.
Publicado: (2019)

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
por: Shah, Vallari, et al.
Publicado: (2020)

Inhibiting MEK in MAPK pathway-activated myeloma
por: Heuck, C J, et al.
Publicado: (2016)

The Clinical Value of Molecular Subtyping Multiple Myeloma Using Gene Expression Profiling
por: Weinhold, N, et al.
Publicado: (2015)

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
por: Chavan, S S, et al.
Publicado: (2017)

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
por: Hemminki, Kari, et al.
Publicado: (2021)

Multiple myeloma: family history and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Patients with precursor disease exhibit similar psychological distress and mental HRQOL as patients with active myeloma
por: Maatouk, Imad, et al.
Publicado: (2019)

Combination of Flow Cytometry and Functional Imaging for Monitoring of Residual Disease in Myeloma
por: Rasche, L, et al.
Publicado: (2018)

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk
por: Chubb, Daniel, et al.
Publicado: (2013)

Mutational processes contributing to the development of multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2019)

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group
por: Hillengass, J, et al.
Publicado: (2017)

An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics
por: Hoang, Phuc H., et al.
Publicado: (2020)

Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients
por: Mahmoudpour, Seyed Hamidreza, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ohkemtjnoj5sqlen51rg5g9t29